Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-19
2009-06-09
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S264100, C514S217060, C514S228500, C514S234200, C540S220000, C540S481000, C540S600000, C544S058200, C544S090000, C544S127000, C544S277000, C544S279000, C546S194000, C546S288000, C546S286000
Reexamination Certificate
active
07544677
ABSTRACT:
The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
REFERENCES:
patent: 7034026 (2006-04-01), Barnett et al.
patent: 2003/0199511 (2003-10-01), Li et al.
patent: 2005/0130977 (2005-06-01), Lindsley et al.
patent: 2005/0159422 (2005-07-01), Lindsley et al.
patent: 2005/0182256 (2005-08-01), Duggan et al.
patent: 2005/0222155 (2005-10-01), Bilodeau et al.
patent: 2005/0288294 (2005-12-01), Duggan et al.
patent: 2006/0270673 (2006-11-01), Duggan et al.
patent: 2007/0043001 (2007-02-01), Bilodeau et al.
patent: 2007/0082906 (2007-04-01), Bilodeau et al.
patent: 2007/0254901 (2007-11-01), Bilodeau et al.
patent: 2008/0009507 (2008-01-01), Cosford et al.
patent: 2008/0015212 (2008-01-01), Barnett et al.
patent: 2008/0280889 (2008-11-01), Bilodeau et al.
patent: 1 679 308 (2006-07-01), None
patent: WO 2003/086394 (2003-10-01), None
patent: WO 2004/096130 (2004-11-01), None
patent: WO 2005/007099 (2005-01-01), None
patent: WO 2005/100356 (2005-10-01), None
patent: WO 2006/065601 (2006-06-01), None
patent: WO 2006/110638 (2006-10-01), None
patent: WO 2006/135627 (2006-12-01), None
Nakatani, et al., J. Biol. Chem., vol. 274, No. 31, Jul. 30, 1999, pp. 21528-21532.
Bellacosa, et al., Int. J. Cancer: 64, 280-285, 1995.
Hanada, et al., Biochimica et Biophysica Acta, vol. 1697, pp. 3-16 (2004).
Bilodeau Mark T.
Cosford Nicholas D. P.
Hartnett John C.
Li Yiwei
Liang Jun
Berch Mark L
Jaisle Cecilia M
Leff Matthew A.
Merck & Co. , Inc.
Muthard David A.
LandOfFree
Inhibitors of Akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of Akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107561